Jong-Han Yu

Jong-Han Yu

UNVERIFIED PROFILE

Are you Jong-Han Yu?   Register this Author

Register author
Jong-Han Yu

Jong-Han Yu

Publications by authors named "Jong-Han Yu"

Are you Jong-Han Yu?   Register this Author

53Publications

1471Reads

50Profile Views

A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning.

Eur J Surg Oncol 2019 02 16;45(2):134-140. Epub 2018 Oct 16.

Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07487983183143
Publisher Site
http://dx.doi.org/10.1016/j.ejso.2018.09.011DOI Listing
February 2019

Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice.

Asian J Surg 2019 Jan 23;42(1):314-319. Epub 2018 Jul 23.

Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.asjsur.2018.06.004DOI Listing
January 2019

Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?

Breast Cancer Res Treat 2019 Jan 20;173(1):189-199. Epub 2018 Sep 20.

Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4947-zDOI Listing
January 2019

A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients.

Breast Cancer Res Treat 2019 Jan 15;173(2):255-266. Epub 2018 Oct 15.

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-4981-x
Publisher Site
http://dx.doi.org/10.1007/s10549-018-4981-xDOI Listing
January 2019

Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea.

BMC Cancer 2019 Jan 17;19(1):84. Epub 2019 Jan 17.

Division of Hematology-Oncology, Departments of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-5258-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337867PMC
January 2019

Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort.

Breast Cancer Res Treat 2018 Oct 21;171(3):737-745. Epub 2018 Jun 21.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-4858-z
Publisher Site
http://dx.doi.org/10.1007/s10549-018-4858-zDOI Listing
October 2018

Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype.

Oncology 2018 18;95(3):163-169. Epub 2018 Jun 18.

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000488944DOI Listing
September 2018

Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer.

J Breast Cancer 2018 Jun 20;21(2):173-181. Epub 2018 Jun 20.

Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4048/jbc.2018.21.2.173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015977PMC
June 2018

Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast.

Transl Oncol 2018 Feb 13;11(1):18-23. Epub 2017 Nov 13.

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Korea; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul 06351, Korea; Biomedical Research Institute, Samsung Medical Center, Sungkyunkwan University, Seoul 06351, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2017.10.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684533PMC
February 2018

Radiation-related heart disease after breast cancer radiation therapy in Korean women.

Breast Cancer Res Treat 2017 Nov 17;166(1):249-257. Epub 2017 Jul 17.

Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4398-yDOI Listing
November 2017

Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes.

Cancer Sci 2016 Jun 27;107(6):828-35. Epub 2016 Apr 27.

Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12935DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968593PMC
June 2016

Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer.

J Clin Pathol 2016 May 16;69(5):422-30. Epub 2015 Oct 16.

Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2015-203089DOI Listing
May 2016

Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer.

Pathol Int 2016 Apr 27;66(4):202-9. Epub 2016 Feb 27.

Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pin.12393DOI Listing
April 2016

Expression of NY-ESO-1 in Triple-Negative Breast Cancer Is Associated with Tumor-Infiltrating Lymphocytes and a Good Prognosis.

Oncology 2015 29;89(6):337-44. Epub 2015 Sep 29.

Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/439535
Publisher Site
http://dx.doi.org/10.1159/000439535DOI Listing
March 2016

High mobility group B1 and N1 (HMGB1 and HMGN1) are associated with tumor-infiltrating lymphocytes in HER2-positive breast cancers.

Virchows Arch 2015 Dec 7;467(6):701-709. Epub 2015 Oct 7.

Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs00428-015-18
Web Search
http://link.springer.com/10.1007/s00428-015-1861-1
Publisher Site
http://dx.doi.org/10.1007/s00428-015-1861-1DOI Listing
December 2015

Development and Validation of a Novel Plasma Protein Signature for Breast Cancer Diagnosis by Using Multiple Reaction Monitoring-based Mass Spectrometry.

Anticancer Res 2015 Nov;35(11):6271-9

Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/35/11/6271.full.pdf
Web Search
November 2015

Clinicopathologic Significance of the Intratumoral Heterogeneity of HER2 Gene Amplification in HER2-Positive Breast Cancer Patients Treated With Adjuvant Trastuzumab.

Am J Clin Pathol 2015 Oct;144(4):570-8

From the Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCP51HCGPOPWSCYDOI Listing
October 2015

Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.

Am J Clin Pathol 2015 Aug;144(2):278-88

From the Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCPIXUYDVZ0RZ3GDOI Listing
August 2015

Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes.

Breast Cancer Res Treat 2015 Jun 26;151(3):619-27. Epub 2015 May 26.

Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-015-3438
Web Search
http://link.springer.com/10.1007/s10549-015-3438-8
Publisher Site
http://dx.doi.org/10.1007/s10549-015-3438-8DOI Listing
June 2015

Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes.

Breast Cancer Res 2015 May 3;17:64. Epub 2015 May 3.

Division of Breast and Endocrine Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-015-0574-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504447PMC
May 2015

Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women.

J Cancer Res Clin Oncol 2015 Apr 17;141(4):633-45. Epub 2014 Oct 17.

Department of Surgery, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-014-1849-2DOI Listing
April 2015

Correlations between molecular subtypes and pathologic response patterns of breast cancers after neoadjuvant chemotherapy.

Ann Surg Oncol 2015 Feb 6;22(2):392-400. Epub 2014 Sep 6.

Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-4054-2DOI Listing
February 2015

Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer.

Cancer Lett 2015 Feb 4;357(2):488-97. Epub 2014 Dec 4.

Department of Biomedical Sciences, Department of Physiology, University of Ulsan College of Medicine, Seoul, South Korea; Asan Medical Center, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2014.11.058DOI Listing
February 2015

Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea.

Fam Cancer 2014 Jun;13(2):205-11

Division of Breast and Endocrine Surgery, Department of Surgery College of Medicine, University of Ulsan, Asan Medical Center, 388-1 Pungnap-dong, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10689-014-9704-9
Publisher Site
http://dx.doi.org/10.1007/s10689-014-9704-9DOI Listing
June 2014

Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer.

Breast Cancer Res Treat 2014 Jun 13;145(3):615-23. Epub 2014 May 13.

Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2983-xDOI Listing
June 2014

Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.

Ann Surg Oncol 2014 May 3;21(5):1561-8. Epub 2014 Jan 3.

Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-013-3456-xDOI Listing
May 2014

Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients.

Eur J Cancer 2014 May 1;50(8):1403-11. Epub 2014 Apr 1.

Department of Surgery, College of Medicine, University of Ulsan and Asan Medical Center, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.02.026DOI Listing
May 2014

A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population.

World J Surg Oncol 2014 Mar 13;12:56. Epub 2014 Mar 13.

Department of Surgery, St, Vincent's Hospital, The Catholic University of Korea, 93, Joongboo-Daero Suwon, Paldal-gu, Kyunggi-do 442-723, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1477-7819-12-56DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995623PMC
March 2014

Association of Human Epidermal Growth Factor Receptor 2 with Radiotherapy Resistance in Patients with T1N0M0 Breast Cancer.

J Breast Cancer 2013 Sep 30;16(3):266-73. Epub 2013 Sep 30.

Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.

View Article

Download full-text PDF

Source
https://synapse.koreamed.org/DOIx.php?id=10.4048/jbc.2013.16
Publisher Site
http://dx.doi.org/10.4048/jbc.2013.16.3.266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800722PMC
September 2013

High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α.

Cancer Lett 2013 Jun 19;333(1):18-31. Epub 2012 Nov 19.

Laboratory of Tumor Suppressor, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2012.11.026DOI Listing
June 2013

Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer.

Breast Cancer Res Treat 2012 Jun 11;133(3):909-16. Epub 2011 Nov 11.

Department of Surgery, University of Ulsan College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-011-1868-5
Publisher Site
http://dx.doi.org/10.1007/s10549-011-1868-5DOI Listing
June 2012

Risk factor for axillary lymph node metastases in microinvasive breast cancer.

Ann Surg Oncol 2012 Jan 2;19(1):212-6. Epub 2011 Jun 2.

Department of Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-011-1812-2DOI Listing
January 2012

Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.

Cancer Epidemiol Biomarkers Prev 2011 May 17;20(5):793-8. Epub 2011 Mar 17.

Cancer Research Institute, Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-10-1282DOI Listing
May 2011

Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer.

Ann Surg Oncol 2009 May 14;16(5):1112-21. Epub 2009 Feb 14.

Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Gyeonggi-Do, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-009-0334-7DOI Listing
May 2009